1. Home
  2. UCAR vs ALBT Comparison

UCAR vs ALBT Comparison

Compare UCAR & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U Power Limited

UCAR

U Power Limited

HOLD

Current Price

$1.60

Market Cap

3.1M

ML Signal

HOLD

Logo Avalon GloboCare Corp.

ALBT

Avalon GloboCare Corp.

HOLD

Current Price

$0.39

Market Cap

3.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UCAR
ALBT
Founded
2013
2014
Country
China
United States
Employees
N/A
N/A
Industry
Retail-Auto Dealers and Gas Stations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
3.3M
IPO Year
2022
2015

Fundamental Metrics

Financial Performance
Metric
UCAR
ALBT
Price
$1.60
$0.39
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$50.00
N/A
AVG Volume (30 Days)
30.3M
604.3K
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.18
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.34
52 Week High
$4.98
$4.74

Technical Indicators

Market Signals
Indicator
UCAR
ALBT
Relative Strength Index (RSI) 56.01 37.32
Support Level $1.54 $0.34
Resistance Level $1.96 $0.62
Average True Range (ATR) 0.56 0.07
MACD 0.03 0.00
Stochastic Oscillator 47.94 18.02

Price Performance

Historical Comparison
UCAR
ALBT

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About ALBT Avalon GloboCare Corp.

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Share on Social Networks: